PCSK9i in AAA1-basrah

Clinical Trial Overview

Recruiting
99 years or below
All
Fase N/A
50 participants needed
1 Location

Brief description of study

Please see section 3 of the full protocol Please see section 3 of the full protocol Please see section 3 of the full protocol

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions:
  • Age: 99 years or below
  • Gender: All

TBD

Updated on 19 Feb 2024. Study ID: TBD23

This clinical trial aims to evaluate the effectiveness of a new treatment for managing chronic pain. Participants will receive either the new treatment or a placebo to compare outcomes. The study seeks to understand the treatment's impact on pain levels and quality of life.

  • Who Can Participate: Adults aged 18-65 with a diagnosis of chronic pain for at least six months
  • Study Details: Participants will be randomly assigned to receive either the new treatment or a placebo. The study will last for 12 weeks, with regular assessments to monitor progress
  • Study Timelines and Visits: The study will begin in January 2024 and conclude in March 2024.Participants are required to attend 5 visits over the course of the study

Find a site

We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Preferred way of contact
Race
Ethnicity
Other language